ArticleCureus2025
Primary Epstein-Barr Virus Infection Presenting as Cholestatic Hepatitis Without Infectious Mononucleosis in an Immunocompetent Middle-Aged Adult: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus (EBV) infections commonly present with a subclinical hepatitis, often in the context of infectious mononucleosis (IM). A 56-year-old male presented with fever, alongside signs of jaundice and right upper quadrant tenderness. Initial investigations revealed marked cholestatic hepatic dysfunction, but imaging showed no evidence of biliary tree pathology. Serological and molecular testing confirmed primary EBV infection, whilst excluding other viral and autoimmune causes of hepatitis. The patient was managed conservatively, with rapid normalisation of liver function during outpatient follow-up. The rare occurrence of cholestatic hepatitis secondary to primary EBV infection in an immunocompetent middle-aged adult, and the lack of typical IM symptoms - including rash, pharyngitis, and lymphadenopathy - makes diagnosis challenging and complex. Given the rare but potentially fatal risk of progression to acute liver failure, and the atypical presentation, EBV should be high on the list of differentials in cases of acute cholestatic hepatitis in the absence of other IM features, particularly in middle-aged and older adults. Once common aetiologies have been excluded, early targeted EBV serological and molecular tests are key to avoiding unnecessary invasive investigations and inappropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.